MedPath

Outcome Indicators of Non-surgical Therapy of Peri-implantitis

Not Applicable
Completed
Conditions
Infections
Peri-Implantitis
Interventions
Procedure: Non surgical debridement of peri-implantitis
Registration Number
NCT05539755
Lead Sponsor
Universitat Internacional de Catalunya
Brief Summary

Objectives: To identify patient and implant indicators influencing the non-surgical therapeutic outcomes of peri-implantitis at 6-months follow-up.

Material and methods: This prospective cohort study included patients with at least one implant diagnosed with peri-implantitis according to the 2017 World Workshop. Non-surgical therapy consisted in a mechanical debridement of the peri-implant pockets combined with the metronidazole 500 mg every 8 hours during 7 days. At baseline and at 6 months, clinical and radiographic variables were collected to calculate the success of the therapy. The influence of patient and implant/prosthetic variables on disease resolution were assessed trough simple and multiple logistic regression analysis at patient and implant level using generalized estimation equations models.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Subjects over 18 years old
  • At least one implant in function for more than 1 year diagnosed with peri-implantitis following the case definition of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018).
Read More
Exclusion Criteria
  • Previous surgical therapy of peri-implantitis
  • Allergy to metronidazole
  • Clinical implant mobility
  • Pregnancy or lactating females
  • Previous non-surgical treatment (i.e., submucosal debridement) of the affected implants at least 12 months before
  • Use of systemic antibiotics during the previous 3 months as well as use of systemic antibiotics for endocarditis prophylaxis,
  • Systemic diseases, medications, or conditions that may compromise wound healing and influence the outcome of the therapy.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Non-surgical therapy of peri-implantitisNon surgical debridement of peri-implantitisSubjects over 18 years old were consecutively included in the study if they present at least one implant in function for more than 1 year diagnosed with peri-implantitis following the case definition of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (Berglundh et al., 2018).
Primary Outcome Measures
NameTimeMethod
Disease resolution6 months

Probing pocket depth reduction to 5 mm without bleeding on probing (BoP) or \<5 mm irrespective to BoP in all implant sites together with lack of progression of peri-implant bone loss

Secondary Outcome Measures
NameTimeMethod
ChangesFrom baseline to 6 months

Measured in mm from the mucosal margin to mucogingival line in 6 sites per tooth

Plaque index (PI)From baseline to 6 months

Calculated by assigning a binary score to each surface (1 for plaque present, 0 for absent).

Changes in Bleeding on probing (BoP)From baseline to 6 months

Assessed dichotomously (yes/no) in six sites per tooth

Changes in soft tissue marginFrom baseline to 6 months

Measured in mm from the mucosal margin to the most apical portion of the crown in 6 sites per tooth

Changes in Suppuration on probing (BoP)From baseline to 6 months

Assessed dichotomously (yes/no) in six sites per tooth

Changes in PPDFrom baseline to 6 months

Measured in mm from the mucosal margin to the base of the peri-implant pocket in 6 sites per tooth

Trial Locations

Locations (1)

Universitat Internacional de Catalunya

🇪🇸

Barcelona, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath